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High-resolution 3-D rendering of a blastocyst (early development stage of the fetus).
Copyright istockphoto.com. Photo by Geopaul.

n July 2006 the Senate passed
the Stem Cell Research
Enhancement Act.1 The House
of Representatives had passed
the bill, referred to as H.R. 810,
in May 2005. The day after the Senate
vote, President Bush vetoed the
legislation. It was the first time he
exercised the veto power in almost six
years in office. That day, the House
voted to override the veto. The vote
was 235 to 193, less than the two-thirds
majority needed to set aside a
presidential veto.

I

H.R. 810 did not aim to legalize human
embryonic stem cell research. It
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already was legal. It would, however,
have expanded federal funding for
human embryonic stem cell research.
On its face, the proposed statute
appeared to be a fairly straightforward
appropriations bill. In fact, the bill sat
at the center of a far-reaching and
intense public debate about embryos,
abortion, personhood, and the character
of society.
The day before Bush vetoed the bill,
his press secretary, Tony Snow,
announced that the president “believes
strongly that for the purpose of research
it’s inappropriate for the federal
government to finance something that
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many people consider murder. He’s one
of them.”2 Within a week, Snow
recanted his use of the word “murder.”
He explained that he had “overstated
the president’s position.”3 The
retraction seemed to have been
grounded in concern about alienating
and causing political harm to a wide
group of Republicans who favor human
embryonic stem cell research and who
were not likely to have been pleased
by the president’s referring to them as
murderers.
Snow’s comment and his speedy
retraction suggest the complicated
parameters of a debate that

encompasses disagreements about
embryos, families, gender and
personhood (what it means to be a
person). The social and political debate
that surrounds the bill that Bush vetoed
encompasses the discordant beliefs that
surround discussions about abortion in
the United States. It alludes more
broadly still to disagreements about
science, religion and politics.

replace dying or injured cells, tissues
and organs with new ones.7 In
particular, hES cell research may bring
insight into the mechanisms behind, and
lead to treatments for, disabilities and
diseases, including cancer, heart
disease, Alzheimer’s disease, multiple
sclerosis and spinal cord injury.8 But
the research is controversial because it
results in the destruction of embryos.

Public interest in stem cell research
followed the isolation of human
embryonic stem cells (hES cells) in
1998 by a group of scientists at the
University of Wisconsin.4 hES cells are
extracted from an embryo in the
blastocyst stage of development (about
five days after fertilization when the
embryo contains approximately 200
cells). hES cells hold promise for
science and for health care because
of their capacity for self-renewal and
their capacity to differentiate into
specialized cells in the body such as
muscle, heart or insulin-secreting cells.5
Other types of stem cells (“adult” stem
cells, for instance) are self-renewing
and can differentiate into specialized
cells. However, unlike hES cells, adult
stem cells are not pluripotent. They are
limited in the types of specialized cells
into which they can differentiate.6 In
addition, their capacity for self-renewal
is much smaller than that of hES cells.

Almost inevitably in light of the
intensity of the controversy about
abortion in the United States, the
suggestion that embryos should be used
in research that destroys them has
resulted in the conflation of the debate
about hES cell research with the older
debate about abortion, which has, in
turn, long been part of a much wider
debate about gender, personhood, and
the meaning of family relationships in
the United States.

Scientists widely believe that the
unusual qualities of hES cells justify
hope that remarkable new forms of
medical care may develop out of hES
cell research. This research allows
scientists to study cell development and
cell death, to test the usefulness and
risks of pharmaceutical agents, and, it is
hoped, will one day allow doctors to
actualize a new form of regenerative
medicine that will enable them to

In the October 25, 2004, issue of Newsweek
(on newsstands Monday, October 18),
“The Battle Over Stem Cells,” Newsweek
reports on the newest wedge issue in the
presidential campaign that may swing some
voters. Image courtesy of NewsCom.
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hES cells
hold promise
for science
and for
health care ...
These older debates have their roots in
the late 19th century, when a set of
social and economic forces began to
challenge the so-called traditional
family. The traditional family, forged
in the early years of the Industrial
Revolution, was defined in stark
contrast with the marketplace. The
traditional family was defined through
reference to love and biology. In
contrast, the marketplace was defined
through reference to money and choice.
While relations at home were expected
to follow fixed roles and to endure,
relationships at work were expected to
be the product of negotiated choices
and to last only as long as the bargains
on which they were predicated. The
traditional family, which survived the
19th century, to reach a heyday of sorts
in the middle decades of the 20th
century, ideally included a married
couple of opposite genders and their
biological children. Only in the last
decades of the 20th century, did the
traditional family begin to be openly
replaced with another form of family,
grounded in choice and autonomous
individuality.
Opposition to abortion was long
connected expressly with protection of
traditional family life. Those who

HOFSTRA horizons

5

... during the
decades after
Roe, the debate
about abortion
permeated
American
discourse about
the scope
of personhood
and the meaning
of families.
opposed abortion in the 19th and
throughout much of the 20th centuries
were generally also opposed to
feminism and to the dismantling of set
roles and statuses within family
settings. Over time, especially as vast
demographic changes in family life
transformed the American family in
fact, if not always in theory, those
opposing abortion found it more
difficult to rely openly on opposition to
modern forms of family in pressing a
pro-life platform. Thus they began to
focus more and more intently on the
sanctity of fetal life and less openly on
opposing modernity in family settings.
By the last decades of the 20th century,
that shift had become strategically
valuable for the pro-life movement.
Particularly after the U.S. Supreme
Court granted women a limited right to
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abortion in 1973 in Roe v. Wade,9 the
pro-life movement energized itself
around the claim that fetuses enjoy
personhood and that, accordingly,
abortion is murder. As a matter of
strategy, that position proved very
effective. It allowed the pro-life
movement to advance an agenda that
continued, at bottom, to support the
preservation of traditional families
while largely eliding actual discussions
about family patterns, and, more
particularly, about gender equality.
That was important for the pro-life
movement insofar as the larger society
had began to concede that family
relationships should be built around
individual choice and freedom and was
thus likely to dismiss exhortations
about the value of safeguarding
traditional patterns of family
relationships. By the end of the 20th
century, people were, in fact, choosing
to marry or not, to stay married or not,
and to shape family relationships on a
wide set of new models.
Moreover, the pro-life movement’s focus
on fetuses and embryos (rather than on
safeguarding traditional views of gender
and of family life) posed a stumbling
block for pro-choice adherents. In the
last decades of the 20th century, even
feminists, deeply committed to
preserving the right to abortion, were
reluctant to entertain public discussion
of fetal status or to challenge the notion
of fetal personhood.
And so, during the decades after Roe,
the debate about abortion permeated
American discourse about the scope of
personhood and the meaning of families.
On its face, it had largely become a
debate about the status of the fetus and
the embryo. Yet, it continued to provide
a cultural context for considering –
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although often implicitly – gender,
personhood, and the scope and meaning
of family relationships. In particular,
Americans debated, whether selfconsciously or not, the comparative
value of grounding familial relationships
on traditional patterns and communal
ties or of grounding them on the open
choices of autonomous individuals. The
reluctance of pro-choice adherents to
challenge pro-life claims about fetal and
embryonic life gave the pro-life
movement a decided advantage during
these years.
Then with the advent of hES cell
research and the remarkable promise
that embryonic stem cell research
offered to a nation convinced that health
is equivalent to salvation,10 the pro-life
movement met a potential nemesis.
In 2001, as the issue of hES cell
research and various modes of
producing embryos for research,
including cloning, energized public
discourse, President Bush announced a
compromise solution to disagreements
about whether the federal government
should fund hES cell research. The
president precluded federal funding for
hES cell lines not in existence on the
date of his announcement (Aug. 9,
2001), but he provided that federal
funds could be used in research on
extant hES cell lines.11 On that day, as
on the day of his veto of H.R. 810,
almost five years later, Bush appeared
with a group of children presumptively
“adopted” as embryos. He thus focused
public attention on the personhood of
embryos by highlighting their potential
to develop into people.
Yet, even as Bush opted (in 2001 and
again in 2006) not to countenance
federal funding for hES cell research,

he openly acknowledged a commitment
to science and technology. But he
balanced that concern against concern
for embryonic life. On the one hand,
Bush explained in 2001, he had faith in
the potential of hES cell research to
effect “incredible good.” But, on the
other hand, he noted, “human life is a
sacred gift from our Creator.” “I worry,”
he continued, “about a culture that
devalues life.” 12
Some individuals and groups that have
long opposed abortion, including the
Catholic church, remain steadfast in
their opposition to all forms of hES cell
research. Other pro-life adherents,
however, have gone much farther than
Bush in supporting hES cell research.
In doing that, they have redefined the
language through which the debate
about abortion is being voiced and
have, potentially, weakened the impact
of pro-life claims about the sanctity of
embryonic life.
In 2002, for instance, Senator Orrin
Hatch, a pro-life senator from Utah,
explained his decision to support a bill
providing for research cloning, a
procedure that would produce human
embryos for research purposes.
Embryonic research, Hatch explained,
is “pro-life and pro-family.” 13 Thus
Hatch – employing the very term
(pro-life) that identified his position
about embryos in the debate about
abortion – bifurcated discourse about
embryos. Embryos in the context of
the abortion debate, Hatch suggested,
are simply different from embryos in
the context of hES cell research.
The first sort of embryo enjoys
personhood; the second does not.
Hatch explained, referring to embryos
created through research cloning:

It used to be a fertilized egg was a
human being. Now, it’s an unfertilized
egg, as long as you put a skin cell
in that gives 46 chromosomes.
To me, it’s a big stretch. Every day
you shower, you shower off millions
of living human cells.14
Yet from a biological perspective, the
embryo formed from the insertion of
the nucleus of a skin cell (or any other
somatic cell) into an unfertilized egg is
as much an embryo as one formed from
an egg fertilized inside a woman’s body.
Similarly, former Senator Connie Mack,
an abortion opponent from Florida,
justified support for hES cell research
and research cloning as a mode of
producing embryos for hES cell
research. As Senator Hatch had done,

Senator Mack separated the debate
about hES cell research and research
cloning from the debate about abortion.
In the debate about hES cell research,
Mack explained, if you use embryos
created from cloning “[y]ou’re using an
egg that has never been fertilized by
sperm and is never placed in a uterus.
The words that we’re using were
defined in a former age.”15
Both Senators Hatch and Mack set the
stage for new understandings of phrases
that remain at the center of the debate
about abortion – phrases such as
“embryonic life” and “embryonic
status”– and in doing that, they
participated in shaping a moral vision
of embryos that they presumed did not
implicate conclusions about embryos in
the context of abortion.

Embryonic stem cells (ES cells) under a microscope. Copyright istockphoto.com.
Photo by Andrei Tchernov.
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people in persistent vegetative states) or
consideration of the right to samegender marriage provide alternative
contexts within which Americans have
been able to consider the meaning of
personhood and to compare the value of
various patterns of family relationship.
Still other contexts for continuing the
debate about families and gender
may emerge as new issues are framed
in old terms.

... the debate
about hES
cells may signal
the start of
a genuinely new
era — in medicine,
in science, and
in visions of what
it means to be
a person.
In part, this new mode of discourse
seems to have softened the edges of the
debate about embryos and seems,
inevitably perhaps, to be shifting oncesecure alliances in the debate about
abortion. After Bush vetoed H.R. 810,
about two-thirds of the American people
voiced support for hES cell research.
Yet, the debate about abortion continues
and remains embedded inside a larger
debate about families, gender and
personhood. Perhaps that larger debate
will itself fade as more and more
people opt to view family relationships
through the metaphors of choice and
bargain rather than those of gender
status and fixed, enduring family roles.
Or perhaps, instead, the larger debate
about families will continue to engage
society but will more and more often be
voiced in terms that elide the debate
about abortion. So, consideration of
end-of-life issues (involving questions,
for instance, about the personhood of
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Or the debate about hES cells may
signal the start of a genuinely new era –
in medicine, in science, and in visions of
what it means to be a person. If the
promise of regenerative medicine, based
on the use of hES cells, is actualized,
medicine will be able to provide
individualized care, even individualized
body parts to replace parts compromised
by age, disability or illness. This sort of
individualized health care provides an
apt metaphor for a society that
increasingly prizes choice and autonomy
in family relationships as wholeheartedly
as it has long prized choice and
autonomy in the marketplace.

Many of the issues discussed in this essay
are considered in greater detail in other
places. See, e.g., Janet L. Dolgin,
Embryonic Discourse: Abortion, Stem
Cells, and Cloning, 31 Flor. S. U. L. Rev.
101 (2003); Surrounding Embryos: Biology,
Ideology, and Politics, 16 Health Matrix 27
(2006); New Terms for An Old Debate, 6
Hous. J. Health L. & Pol’y 245 (2006).
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